0001192482-18-000350.txt : 20180718
0001192482-18-000350.hdr.sgml : 20180718
20180718162917
ACCESSION NUMBER: 0001192482-18-000350
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180614
FILED AS OF DATE: 20180718
DATE AS OF CHANGE: 20180718
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bayley Matthew D
CENTRAL INDEX KEY: 0001723040
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35112
FILM NUMBER: 18958684
MAIL ADDRESS:
STREET 1: C/O AEVI GENOMIC MEDICINE, INC.
STREET 2: 435 DEVON PARK DR., SUITE 715
CITY: WAYNE
STATE: PA
ZIP: 19087
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aevi Genomic Medicine, Inc.
CENTRAL INDEX KEY: 0001138776
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 980217544
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 435 DEVON PARK DRIVE,
STREET 2: SUITE 715
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 610-254-4201
MAIL ADDRESS:
STREET 1: 435 DEVON PARK DRIVE,
STREET 2: SUITE 715
CITY: WAYNE
STATE: PA
ZIP: 19087
FORMER COMPANY:
FORMER CONFORMED NAME: MEDGENICS, INC.
DATE OF NAME CHANGE: 20090623
FORMER COMPANY:
FORMER CONFORMED NAME: MEDGENICS INC
DATE OF NAME CHANGE: 20010419
4/A
1
edgar.xml
PRIMARY DOCUMENT
X0306
4/A
2018-06-14
2018-06-19
0001138776
Aevi Genomic Medicine, Inc.
GNMX
0001723040
Bayley Matthew D
C/O AEVI GENOMIC MEDICINE, INC.
435 DEVON PARK DRIVE, SUITE 715
WAYNE
PA
19087
1
0
0
0
Stock Option (Right to Purchase)
1.55
2018-06-14
4
A
0
50000
0
A
2028-04-17
Common Stock
50000
50000
D
The option award was granted on April 17, 2018 and was subject to forfeiture if stockholder approval of a proposed amendment to the Issuer's stock incentive plan to increase the number of shares reserved for issuance under the plan was not obtained. The Issuer's stockholders approved the amendment to the Issuer's stock incentive plan at the Issuer's annual meeting of stockholders on June 14, 2018.
This amendment is being filed to amend the vesting schedule of the option award. The entire option award vests and becomes exercisable on April 17, 2019, subject to the reporting person's continued service with the Issuer. The reporting person is the Chief Strategy Officer at The Children's Hospital of Philadelphia and he holds this option award for the benefit of The Children's Hospital of Philadelphia Foundation.
/s/ Brian D. Piper as Attorney-in-Fact for Matthew D. Bayley
2018-07-18